Neuro-Oncology Reviews

Volume 27 Number 33
30 November 2025

Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 33, 30 November

Antoni D, Mesny E, El Kabbaj O, Robert C, Quintin K, Feuvret L, Biau J, Jacob J.
Radiotherapy guidelines for gliomas: 2025 update.
Cancer Radiother. 2025 Nov 21;29(7-8):104774. doi: 10.1016/j.canrad.2025.104774. PMID: 41273888. Guidelines. ˍ

Bell MS, Walton CM, Williams MJ, Eckert T, Brown JC, Rowland NC, Sahin O, Strickland BA.
Engineering focused ultrasound for glioblastoma.
Brain Stimul. 2025 Nov 21;19(1):102986. doi: 10.1016/j.brs.2025.102986. PMID: 41276162. Review. ˍ

Cvitković J, Tan WL, Jiang T, Zhao Z.
Glioma tumor microenvironment and immunotherapy: past, present, and future.
Biomark Res. 2025 Nov 21;13(1):150. doi: 10.1186/s40364-025-00863-2. PMID: 41272822. Review. ˍ

Geens W, Rizani G, Del Gaudio N, Buyck F, Van Gestel F, Bruneau M, Neyns B, Duerinck J.
Extent of resection and its association with overall survival in newly diagnosed IDH wildtype glioblastoma treated with concomitant radiochemotherapy: a systematic review and meta-analysis.
Brain Spine. 2025 Nov 21;5:105867. doi: 10.1016/j.bas.2025.105867. PMID: 41450869. Review; Meta-analysis. ˍ

Mignone C, Khuong-Quang DA.
Diffuse Pediatric High Grade Gliomas.
Neuroimaging Clin N Am. 2025 Nov 21;36(1):35-51. doi: 10.1016/j.nic.2025.09.004. PMID: 41274769. Review˰ ˍ

Lombardi G, Baro V, Landi A.
Adult Gliomas: From Molecular Insight to Clinical Horizons.
Curr Oncol. 2025 Nov 24;32(12):659. doi: 10.3390/curroncol32120659. PMID: 41440187. Editorial. ˍ

Mastronuzzi A, Franceschi E, D'Antonio F, Bennicelli E, Berzero G, Cella E, Filippi M, Lanzetta G, Marchioni E, Milanaccio C, Simonelli M, Bini P, Silvani A, Pace A.
Diagnostic and predictive molecular biomarkers in brain tumors across the lifespan: an age-stratified consensus statement.
J Neurooncol. 2025 Nov 24;176(1):95. doi: 10.1007/s11060-025-05329-x. PMID: 41284071. Review. ˍ

Mehfooz M, Raza H, Javed A, Ejaz Y.
CAR-T in Central Nervous System Tumours: Promising Science, Slow Clinical Progress.
Clin Oncol (R Coll Radiol). 2025 Nov 24;49:103986. doi: 10.1016/j.clon.2025.103986. PMID: 41442796. Perspective. ˍ

Rossi J, Picca A, Santonocito OS, Schembari S, Testaverde L, Sanson M, Berzero G, Di Stefano AL.
Advances in the management of patients with idh-mutant glioma.
Oncologist. 2025 Nov 24:oyaf391. doi: 10.1093/oncolo/oyaf391. PMID: 41284931. Review. ˍ

Xu D, He L, Zhao X, Yang Z.
Bibliometric evaluation of research trends and hotspots concerning the interaction between immune checkpoint inhibitors and glioma.
Discov Oncol. 2025 Nov 24;16(1):2144. doi: 10.1007/s12672-025-04013-w. PMID: 41284174. Bibliometric analysis. ˍ

Bria J, Filardo A, Di Vito A, Della Torre A, Lavano A, Coscarella I, Chiarella E, Procopio E, Egiziano MT, Longo P, La Torre D.
Recurrent Limitations of CAR-T Therapy in Gliomas: Evidence from Preclinical and Phase I Clinical Studies.
Int J Mol Sci. 2025 Nov 26;26(23):11435. doi: 10.3390/ijms262311435. PMID: 41373591. Review. ˍ

Fanuzzi M, Zheng S, Horbinski CM, Shaaban MA, Congivaram H, Du R, Tripathi S, Hurley L, Kumthekar P, Ahmed A, Brat DJ, Lesniak MS, Heimberger AB.
Targeting Survivin: Now I Become Death, the Destroyer of Cells.
Int J Mol Sci. 2025 Nov 26;26(23):11417. doi: 10.3390/ijms262311417. PMID: 41373575. Review. ˍ

Stathopoulos A, Glorieux P, Rokas EM, Savelkoul HFJ.
Combined Tumor Cell and Lysate-Based Vaccines for Immunotherapy of Primary and Recurrent Glioblastoma (GBM).
Cancers (Basel). 2025 Nov 26;17(23):3772. doi: 10.3390/cancers17233772. PMID: 41374974. Review. ˍ

Zoi V, Galani V, Sioka C, Alexiou GA, Kyritsis AP.
Immunotherapy for Glioblastoma: A Focus on PD-1/PD-L1 Inhibitors.
Cancers (Basel). 2025 Nov 26;17(23):3777. doi: 10.3390/cancers17233777. PMID: 41374979. Review. ˍ

Daher A, Jaber MY, Maraka S, Vemaganti H, Valyi-Nagy T.
Extraneural Metastasis in Oligodendroglioma: A Comprehensive Review and Outcome Analysis of 90 Cases.
Cancer Sci. 2025 Nov 27. doi: 10.1111/cas.70275. PMID: 41310947. Review. ˍ

Himic V, Ramsoomair CK, Soldozy S, Komotar RJ, Ivan ME, Shah AH.
The Future of Clinical Trials in Surgical Neuro-Oncology Is Bright.
Brain Sci. 2025 Nov 27;15(12):1274. doi: 10.3390/brainsci15121274. PMID: 41440070. Editorial. ˍ

Vargas LO, Himic V, Otaner F, Abikenari M, Chandar J, Govindarajan V, Kreatsoulas D, Jahangiri A, Komotar RJ, Ivan ME, Shah AH.
Modulating the glioma microenvironment with laser interstitial thermal therapy: mechanisms and therapeutic implications.
J Neurooncol. 2025 Nov 27;176(1):99. doi: 10.1007/s11060-025-05305-5. PMID: 41307758. Review. ˍ

Zagozewski J, Haldipur P, Millen KJ, Werbowetski-Ogilvie TE.
Medulloblastoma stem cell programs: Molecular roadmaps of disease progression.
Dev Cell. 2025 Nov 27:S1534-5807(25)00692-6. doi: 10.1016/j.devcel.2025.10.018. PMID: 41314219. Review. ˍ

Jadhav A, J A, Patel T.
A comprehensive review redefining viruses as therapeutic agents in cancer treatment.
Discov Oncol. 2025 Nov 28. doi: 10.1007/s12672-025-03973-3. PMID: 41313526. Review. ˍ

Soumbasis A, Ueno A, Elliott D, Lama S, Edwards S, Starreveld YP, Zhang Y, Federico P, Sutherland GR, LeVan P, Poon CC.
The glymphatic system and glioblastoma.
Brain. 2025 Nov 28:awaf449. doi: 10.1093/brain/awaf449. PMID: 41310975. Review. ˍ

Mebrahtu AK, Jain V, Moelker EM, Hoyt-Miggelbrink AM, Ayasoufi K, Thompson EM.
Peptide Vaccines for Pediatric High-Grade Glioma and Diffuse Midline Glioma: Current Progress and Future Perspectives.
Vaccines (Basel). 2025 Nov 30;13(12):1215. doi: 10.3390/vaccines13121215. PMID: 41441679. Review. ˍ

Tleubergenov MA, Zhamoldin DK, Baymukhanov DS, Omarova AS, Ryskeldiyev NA, Doskaliyev A, Ukybassova TM, Akshulakov S.
Brain Tumors in Pregnancy: A Review of Pathophysiology, Clinical Management, and Ethical Dilemmas.
Cancers (Basel). 2025 Nov 30;17(23):3854. doi: 10.3390/cancers17233854. PMID: 41375054. Review. ˍ